A phase 1, randomized, placebo-controlled, dose-ranging study to evaluate the safety and immunogenicity of an mRNA-based chikungunya virus vaccine in healthy adults
Christine A. Shaw, Allison August, Stephan Bart, Peta-Gay Jackson Booth, Conor Knightly, Trevor Brasel, Scott C. Weaver, HongHong Zhou, Lori Panther
Topics & Concepts
ReactogenicityMedicineImmunogenicityChikungunyaPlaceboTolerabilityAdverse effectVaccinationImmunologyTiterInternal medicineVirologyVirusAntibodyPathologyAlternative medicineMosquito-borne diseases and controlBiological Research and Disease StudiesVirus-based gene therapy research